0001209191-19-047753.txt : 20190829
0001209191-19-047753.hdr.sgml : 20190829
20190829182654
ACCESSION NUMBER: 0001209191-19-047753
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190828
FILED AS OF DATE: 20190829
DATE AS OF CHANGE: 20190829
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Salter-Cid Luisa
CENTRAL INDEX KEY: 0001766404
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38796
FILM NUMBER: 191067502
MAIL ADDRESS:
STREET 1: C/O GOSSAMER BIO, INC.
STREET 2: 3013 SCIENCE PARK ROAD, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gossamer Bio, Inc.
CENTRAL INDEX KEY: 0001728117
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 475461709
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3013 SCIENCE PARK
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 922-0718
MAIL ADDRESS:
STREET 1: 3013 SCIENCE PARK
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-08-28
0
0001728117
Gossamer Bio, Inc.
GOSS
0001766404
Salter-Cid Luisa
3013 SCIENCE PARK ROAD
SAN DIEGO
CA
92121
0
1
0
0
Chief Scientific Officer
Common Stock
2019-08-28
4
S
0
23748
19.6532
D
150308
D
Common Stock
2019-08-29
4
S
0
26252
20.0868
D
124056
D
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.50 to $19.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Includes 97,908 shares subject to forfeiture, which shares will vest in equal monthly installments as set forth in the restricted stock agreement between the Issuer and Reporting Person so that all of the shares will be released from the forfeiture restriction on November 20, 2021, subject to the Reporting Person's continuous service to the Corporation on each such vesting date. The shares are also subject to certain accelerated vesting provisions as set forth in more detail in the employment agreement between the Issuer and the Reporting Person.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.71 to $20.42 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Jeff Boerneke, Attorney-in-Fact
2019-08-29